Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5656953 | Nutrition | 2017 | 24 Pages |
Abstract
KD treatment promotes negative changes in lipoprotein size and phenotype, contributing to atherogenic risk in these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Patricia Ph.D., Mariana M.A., Daniela Kawamoto R.D., Leticia Ph.D., Antônio Martins Ph.D., Nágila Raquel Ph.D.,